Samsung says its blood pressure monitoring app for Galaxy Watch has been approved by a South Korean regulator and will be available in Q3
The app measures blood pressure when paired with a smartwatch. — Samsung's app that measures blood pressure on its smartwatch has been approved …
Context & Ripple Effects
This approval is the regulatory gate at the start of Samsung's smartwatch health arc: two months later the company began the South Korean rollout of blood pressure monitoring on the Galaxy Watch Active 2, and within a year it had used the same Samsung Health Monitor vehicle to take EKG support to 31 markets.
What started here has since compounded — irregular heart rhythm notifications across 13 markets in 2023, SVP Dr. Hon Pak discussing AI health tooling and even a possible subscription in 2025, and a US blood pressure rollout in 2026 that still requires a traditional upper-arm cuff for calibration. The Q3 2020 launch matters because it established the regulator-cleared template every later market entry reused.
First-order effects
- Galaxy Watch owners in South Korea gain a regulator-approved blood pressure feature in Q3, making Samsung Health Monitor the delivery mechanism for medical-grade readings rather than a fitness add-on.
- Samsung converts a hardware spec into a cleared clinical claim, which is what later allowed the same app framework to carry EKG and heart-rhythm features into dozens of additional markets.
Second-order effects
- Rival wearable makers face a raised bar: once one vendor holds regulatory clearance for cuffless blood pressure, competitors must either pursue their own approvals or concede the 'health device' positioning to Samsung.
- The calibration dependency on a traditional upper-arm cuff keeps cuff manufacturers embedded in the workflow, and gives Samsung a bundled accessory-plus-app relationship with each new market it enters.
Third-order effects
- If the pattern holds, smartwatches consolidate around regulator-approved health platforms where software updates — not new hardware — unlock new clinical capabilities, and vendors like Samsung can layer monetization such as the subscription Dr. Hon Pak has floated onto a cleared base.
- Health authorities become the pacing factor for the wearables market: each country's approval cadence, not chip or sensor roadmaps, determines when features like blood pressure reach users.
The trend: Smartwatches are evolving from fitness trackers into regulator-approved medical devices, with each national clearance expanding the same health-monitoring platform market by market.